Literature DB >> 15479085

Inhibition of peptidylglycine alpha-amidating monooxygenase by exploitation of factors affecting the stability and ease of formation of glycyl radicals.

Brendon J W Barratt1, Christopher J Easton, David J Henry, Iris H W Li, Leo Radom, Jamie S Simpson.   

Abstract

Peptidylglycine alpha-amidating monooxygenase catalyzes the biosynthesis of peptide hormones through radical cleavage of the C-terminal glycine residues of the corresponding prohormones. We have correlated ab initio calculations of radical stabilization energies and studies of free radical brominations with the extent of catalysis displayed by peptidylglycine alpha-amidating monooxygenase, to identify classes of inhibitors of the enzyme. In particular we find that, in closely related systems, the substitution of glycolate for glycine reduces the calculated radical stabilization energy by 34.7 kJ mol(-1), decreases the rate of bromination with N-bromosuccinimide at reflux in carbon tetrachloride by a factor of at least 2000, and stops catalysis by the monooxygenase, while maintaining binding to the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479085     DOI: 10.1021/ja046204n

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

1.  Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Authors:  Neil R McIntyre; Edward W Lowe; Matthew R Battistini; James W Leahy; David J Merkler
Journal:  J Enzyme Inhib Med Chem       Date:  2015-05-29       Impact factor: 5.051

Review 2.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.